The incorporation of GFAP into algorithms with D-dimer and clinical scales contributed to maintaining high specificity, particularly by effectively excluding patients with hemorrhagic stroke, in whom GFAP levels are markedly elevated. The gene discussed is GFAP; the disease is hemorrhagic stroke.